display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - adjuvantbreast cancer - HR positivebreast cancer - triple negative
breast cancer - adjuvantla/mBC - HR positivemBC - TNBC - L2 - all populationmBC - TNBC - L2 - PDL1 positivees-BC - TNBC - NA - all population
pembrolizumab alone KEYNOTE-522 NCT03051659 KEYNOTE-119 ... KEYNOTE-119 ... KEYNOTE-119 ... KEYNOTE-522

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons